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Abstract
Background: Iron deficiency anaemia (IDA) due to occult gastrointestinal (GI) blood loss usually
remains unnoticed until patient become symptomatic. There is sparse data in IDA patients without
gastrointestinal symptoms. This study was designed to find out the frequency and predictors of
endoscopic lesions in IDA without gastrointestinal symptoms. Cross-sectional study performed on
a convenience sample of consecutive subjects.
Methods: Ninety five consecutive patients with laboratory based diagnosis of IDA having no
gastrointestinal symptoms were interviewed and their clinical and biochemical variables were
recorded. All the study patients underwent esophago-gastroduodenoscopy (EGD) and
colonoscopy. Endoscopic findings were documented as presence/absence of bleeding related lesion
and presence/absence of cause of IDA. Multiple logistic regressions were performed to identify
variables significantly related to outcome variables.
Results: Possible cause of anaemia was found in 71% and bleeding related lesions were found in
53% of patients. Upper gastrointestinal tract lesions were found in 41% of patients with bleeding
related lesions. On multivariable logistic regression; advancing age, low mean corpuscular volume
(MCV ≤ 60 fl), and positive fecal occult blood test were predictive factors for bleeding related GI
lesions and cause of IDA
Conclusion: Clinical and Biochemical markers can predict gastrointestinal lesions on endoscopy
in IDA patients without gastrointestinal symptoms. High proportion of upper gastrointestinal
involvement warrants EGD as initial endoscopic procedure however, this needs validation by
further studies.
Introduction
Anaemia is common among general population in devel-
oping Asian countries. Iron deficiency is a common cause
of anaemia either due to poor intake or chronic blood
loss. Iron deficiency anaemia is usually due to chronic gas-
trointestinal (GI) blood loss when there is no obvious
source of bleeding. The standard of care for these patients
with IDA includes evaluation of the Gastrointestinal (GI)
tract for bleeding lesions [1].
Iron deficiency anemia is considered as an alarm sign for
the presence of possible GI malignancies, and inadequate
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of GI tumors especially colorectal cancer [2]. In 20% of
patients with IDA a routine upper and lower GI endos-
copy may not ascertain GI cause during hospital admis-
sion [3].
The available literature, in heterogeneous groups includ-
ing old age patients and postmenopausal women with
IDA, has shown GI lesions in 40 – 70% [4-6]. Studies have
shown that increasing age, male gender, ferritin level,
prior NSAIDs use, positive fecal occult blood test were fac-
tors predictors of endoscopic lesions in patients with IDA
with and without GI symptoms [7-11]. Studies have con-
cluded that prevalence of endoscopic lesions in patients
with IDA without GI symptoms is between 48 – 71%, [9-
12] however there is a sparse data related to factors pre-
dicting GI lesions in this group.
Important implications for the recognition of iron defi-
ciency anaemia include diagnosis and correction of
underlying causes, most of which are identifiable, by
means of conventional upper gastrointestinal endoscopy
and colonoscopy [13] however it remains unresolved
which procedure should be done first [3].
Many studies have concluded that on evaluation of Gas-
trointestinal Tract for IDA; most of the lesions were in
lower GI Tract and have recommended that evaluation for
IDA should be started with lower GI examination [14-16].
There is scanty data to predict the nature and site of GI
lesions in IDA patients without gastrointestinal symp-
toms. Therefore there is a need for studies especially from
developing asian countries, which may establish endo-
scopic findings and their predictors in this group.
Primary aim of the study was to identify the predictors of
gastrointestinal lesions diagnosed endoscopically in
patients with iron deficiency anemia without gastrointes-
tinal symptoms.
Methods
This Cross-sectional study performed on a convenience
sample of consecutive subjects, conducted from May 2006
to August 2007 at Aga Khan University Hospital.
Inclusion criteria [17]
Iron deficiency anemia was defined as hemoglobin con-
centration ≤ 12.5 g/dl for men (normal range, 13.5 to
17.5) and ≤ 10.6 g/dl for women (normal range, 11.6 to
15.8) with at least one of the following laboratory values
consistent with iron deficiency: a serum iron concentra-
tion ≤ 45 μg/dl (normal range 50 to 150) with a transfer-
rin saturation ≤ 10 percent (normal range 16 to 60
percent), serum total iron binding capacity (TIBC) of ≥
400 μg/dl (Normal range 250 – 400) a serum ferritin con-
centration ≤ 20 ng/ml for men (normal range 20 to 450)
and ≤ 10 ng/ml for women (normal range, 10 to 250).
Exclusion Criteria
were: i) active bleeding (active GI loss, epistaxis, menor-
rhagia, heavy menstrual blood loss ii) History of pica iii)
Not willing to consent for EGD and Colonoscopy iv)
Coagulation disorder v) Thalasemia minor v) Patients
with GI symptoms having IDA which included dysphagia,
odynophagia, heartburn, vomiting, anorexia, hemato-
chezia, change in bowel habits, unexplained diarrhea,
new onset constipation (within last 6 months), and local-
ized abdominal pain.
Eligible subjects, already enlisted for EGD and colonos-
copy for Iron deficiency anemia without gastrointestinal
symptoms, referred from out patient clinic, admitted in
ward or seen as a consult by gastroenterology service in
Aga Khan University Hospital, Karachi were enrolled after
informed consent.
Detailed history including leading questions for GI symp-
toms and physical examination were carried out. Baseline
investigations including hemoglobin, total leucocyte
count, platelets with peripheral blood film, iron studies
including: serum iron, total iron binding capacity (TIBC),
transferrin saturation and ferritin were done in all
patients. All patients were subjected to fecal occult blood
testing before endoscopy by using Hemoccult II slides
(SmithKline, Sunnyvale, California.).
Endoscopic procedures were performed in left lateral
position to prevent chances of aspiration and blood pres-
sure, heart rate along with oxygen saturation were moni-
tored every 5 minutes using cardiac monitors. All
procedures were done under conscious sedation with
intravenous midazolam and intravenous fentanyl.
All patients underwent EGD and colonoscopy with cecal
intubation. Bleeding related endoscopic lesions were
biopsied and duodenal and gastric biopsies were taken if
no lesions were found on endoscopy. All upper GI endo-
copies were performed with Olympus GIF-Q 160 video
scope and colonoscopies were performed with Pentax
3500 EC-3840LK video scope.
Following lesions were considered as source of IDA on
UGI endoscopy: Esophagitis with erosions involving at
least 5 mm of the mucosal surface of the esophagus, gas-
tric and duodenal ulcers (>0.5 cm in diameter), carci-
noma, adenomatous polyps (>0.5 cm in diameter), 5 or
more vascular ectasias [18], erosive gastritis or duodenitis
(defined as multiple mucosal defects encircled by ery-
thema), and hiatal hernia with Cameron's erosions, portalPage 2 of 7
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Non-bleeding causes of Iron deficiency anemia included
the following: histopathologically proven celiac disease
[18]. Helicobacter pylori associated chronic gastritis and
atrophic gastritis were considered as a possible cause of
IDA only when all other causes were excluded [8,11,18].
Bleeding related lesions were defined as obvious lesions
on endoscopy which can cause anaemia. Cause of anae-
mia defined as patients with bleeding related lesions and
patients with no obvious bleeding related lesions on
endoscopy but histopathology consistent with possible
cause for anaemia which included helicobacter pylori gas-
tritis, atrophic gastritis and celiac disease.
Following lesions were considered as source of IDA on
colonoscopy: colonic mass, one or more polyps (> 0.5 cm
in diameter), 5 or more vascular ectasias, a vascular ectasia
greater than 0.7 cm in size, colonic ulcer(s), and his-
topathologically proven inflammatory bowel disease
[18]. Diffuse diverticular disease was considered as a pos-
sible cause of IDA only in those patients with no other
causes of blood loss on upper and lower GI endoscopies
[11].
Dependent and Independent variables
Endoscopic lesions including bleeding and non bleeding
causes for IDA were classified according to following out-
come variables i) Absence or presence of bleeding related
lesion ii) Absence/presence of cause of IDA (including
bleeding and non bleeding causes).
Following independent variables were investigated for
each outcome variable age (years), gender (male/female),
hemoglobin level (gm/dl), MCV (fl), serum iron, feacal
occult blood (positive/negative), family history of cancer
(yes/no), weight loss (yes/no), prior therapy for IDA (yes/
no), drug history (NSAIDs [yes/no].
Data Analysis Procedure
Data entered and then analyzed on software Statistical
Packages for Social Sciences (SPSS, Chicago, IL) version
15.
Mean ± standard deviation were computed for continuous
variables of age, hemoglobin, white blood cells, platelets,
MCV, serum ferritin level, serum iron, serum TIBC, trans-
ferrin saturation. Frequency and percentages were calcu-
lated for categorical data like male and female ratio, drug
history, weight loss, family history of GI cancers, prior
therapy for IDA, fecal occult blood, gastrointestinal
lesions.
Univariate analysis was performed by using simple logis-
tic regression for association between independent and
outcome variables. A p-value ≤ 0.05 was considered statis-
tically significant. All the variables with p-value ≤ 0.25
were included in multiple logistic regression analysis.
Multivariable logistic regression was used to predict gas-
trointestinal lesions with clinical and biochemical varia-
bles.
Results
Two hundred fifty patients underwent endoscopy for iron
deficiency anaemia with and without gastrointestinal
symptoms during the study period. Ninety five patients
met the inclusion criteria. Table 1 shows demographic
and biochemical characteristics of patients
Out of ninety five patients endoscopic lesions were found
in 50 (52.6%) of patients. Endoscopic lesions were pre-
dominantly in upper gastrointestinal tract. Figure 1 shows
site of endoscopic lesions in gastrointestinal tract.
Seventeen patients had no obvious endoscopic lesion but
on histopathological examination had either helicobacter
associated gastritis or celiac disease, the later was con-
firmed on serologic testing. Table 2 shows etiology for the
cause of iron deficiency anaemia in patients without gas-
trointestinal symptoms.
In upper gastrointestinal tract five patients had malig-
nancy out of which one had oesophageal adenocarci-
noma, two had gastric adenocarcinoma, one had gastric
lymphoma and one had gastrointestinal stromal tumor
(GIST). In lower gastrointestinal tract three patients had
ulcerative colitis, two had colonic carcinoma and two had
colonic tuberculosis with involvement of cecum and ter-
minal ileum.
On univariate analysis age (p < 0.001), hemoglobin (p =
0.04), MCV ≤ 60 fl (p = 0.003), hemoglobin ≤ 9 gm/dl (p
Table 1: Demographic characteristics and biochemical variables 
of patients with asymptomatic iron deficiency anaemia (n = 95)
Gender Male/Female 48/47
Age (yrs) 52.1(16.8)
NSAID users 22 (23.2%)
Hx of Weight loss 29 (30.5%)
Hx of Fatigue/Lethargy 18 (18.9%)
Family Hx of GI cancers 02 (2.1%)
Prior Hx of IDA therapy 09 (9.5%)
Hemoglobin (Hb) (gm/dl) 7.1(2.0)
Mean corpuscular volume (MCV) (fl) 61.2(5.6)
Serum Iron (μg/dl) 11.5(6.1)
TIBC (μg/dl) 388(84)
Transferrin saturation (%) 4.3(2.5)
Ferritin (ng/ml) 6.1(3.8)
Feacal Occult Blood (FOB) Positive 30 (31.6%)Page 3 of 7
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significantly related to bleeding related endoscopic
lesions (Table 3, 4). On multivariable logistic regression
analysis MCV ≤ 60 fl (OR 3.5, 95%CI 1.2 – 10.0), FOB
(OR 16.4, 95% CI 3.9 – 67.3) and age (OR 1.05, 95% CI
1.02 – 1.07) were found independent predictors for
bleeding related endoscopic lesions in patients with IDA
without gastrointestinal symptoms.
For cause of iron deficiency anemia which included bleed-
ing and non bleeding related etiologies; age (p = 0.004),
MCV ≤ 60 fl (p < 0.001), hemoglobin ≤ 9 gm/dl (p =
0.06), TIBC (μg/dl) (p = 0.04) and positive fecal occult
blood (p = 0.001) were significant factors associated with
cause of iron deficiency anemia on univariate analysis. On
Multivariable logistic regression analysis after adjusting
for confounding factors age in years (OR 1.04, 95% CI
1.01 – 1.08), MCV ≤ 60 fl (OR 14.8, 95% CI 3.6 – 60.7),
fecal occult blood positive (OR 7.8, 95% CI 1.46 – 41.8)
were independent predictors of the cause of iron defi-
ciency anemia endoscopically (Table 5, 6)
Receiver operating characteristics (ROC) analysis for
bleeding related lesions showed area under curve 85%
with CI 95% between 77 – 92% while ROC analysis for
overall cause of anaemia showed area under curve 88%
wit 95% CI between 81–95% (Fig 2 and 3).
Discussion
Iron deficiency anaemia due to chronic blood loss is usu-
ally silent and becomes evident when patients become
symptomatic [19]. Studies in patients with IDA without
gastroenterological symptoms are few and have small
number of patients and are in different groups of patients.
It is difficult to conclude that what is usual pattern of dis-
eases, factor which can predict the endoscopic out come
in IDA patients without gastrointestinal symptoms.
We have scanty data in Asian population regarding endo-
scopic evaluation of IDA patients especially without gas-
trointestinal symptoms. Furthermore it is unresolved
Graph showing ROC curve for bleeding related lesionFigure 2
Graph showing ROC curve for bleeding related 
lesion.
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Table 2: Etiology for iron deficiency anaemia without 
gastrointestinal symptoms
Bleeding Lesions No (%)
Upper gastrointestinal Lesions
Hiatal Hernia with Cameron Lesion 2 (2.1)
Erosive oesophagitis 6 (6.3)
¶Oesophageal Mass 01(1.1)
Erosive Gastritis 08(8.4)
Gastric Ulcer 05(5.3)
‡Gastric Mass 03(3.2)
†Gastric polyp 04(4.2)
Hypertensive Portal Gastropathy 02(2.1)
Erosive Duodenitis 03(3.2)
Duodenal ulcer 05(5.3)
Lower Gastrointestinal Lesion
Colonic Ulcer 04(4.3)
††Colonic Mass 02(2.1)
*Colonic Polyp 02(2.1)
Vascular Ectasia in Colon 01(1.1)
Diffuse Diverticular Disease 01(1.1)
Both Upper and Lower gastrointestinal lesion
Erosive Oesophagitis + Colonic ulceration 01(1.1)
Non Bleeding Lesions
Helicobacter related Gastritis 14(14.7)
Celiac Disease 03(3.2)
No Endoscopic or Histopathologic lesion 27 (28.4)
¶Adenocarcinoma, ‡2 were adenocarcinoma, one lymphoma †one 
GIST, 3 hyperplastic polp, †† adenocarcinoma, * hyperplastic polyp.
Site of Involvement of gastrointestinal tract (Percentage)Figure 1
Site of Involvement of gastrointestinal tract (Per-
centage).
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lower GI endoscopic examination.
Available data in patients with IDA having gastrointesti-
nal symptoms the prevalence of getting endoscopic
lesions is up to 70% [4-6] while in asymptomatic IDA
patients the cause (bleeding and non-bleeding) was found
in 85% [11] and bleeding related lesions were found in 37
– 44% [11,20]. In this study we had 53% of patients with
bleeding related cause for IDA and overall cause of IDA
(bleeding and non bleeding lesions) was 71% on upper
and lower GI endoscopy.
Three patients had celiac disease while14 patients had
Helicobacter pylori associated gastritis. It is now recog-
nized that celiac disease can present as IDA without any
gastrointestinal symptoms [21,22]. Similarly studies have
shown helicobacter pylori infection association with
increase in prevalence of IDA [11,18,23].
In this cohort, the frequency of lesions involving lower
gastrointestinal tract was low which is striking and con-
trary to the studies in Caucasian population, in which
lower GI lesions were more or equal to upper GI tract
[2,9,15]. Another prominent finding in our study was
small number of patients had malignancies. Only two
patients had colonic malignancy which is again dissimilar
to the available data which ranges from 10% to 50%
patients [11,15,20,24]. Lower proportion of malignancy
in this study may be explained on the basis of lower inci-
dence of gastrointestinal polyps in Asian population [25].
Studies have suggested bidirectional endoscopic evalua-
tion as a workup of IDA and most of them recommended
lower gastrointestinal endoscopy first [26,27]. In our
study only 10% of patients had colonic involvement
while 61% had bleeding and non bleeding causes in
upper gastrointestinal tract. Lesions involving both the
tracts were present in one patient. Result of this cohort
favors that endoscopic evaluation of the upper gastroin-
testinal tract first.
Table 3: Univariate analysis: Clinical and biochemical factors related to bleeding lesions on endoscopy
Endoscopic lesions Identified 
(n = 51)
No endoscopic lesions 
Identified (n = 44)
Odds ratio 95%CI P value
Clinical variables
Age (yrs) Mean (SD) 57.3(14.5) 49.3(17.4) 1.04 1.01 – 1.07 <0.001
Age ≥ 55 yrs † 30(58.8%) 10 (22.7%) 4.8 1.9 – 11.9 <0.001
NSAID users †† 16(31.4%) 06(13.6%) 2.8 1.0 – 8.2 0.04
Hx of Weight loss ††† 16(31.4%) 13(29.5%) 1.0 0.4 – 2.6 0.84
Hx of Fatigue/Lethargy ¶ 13(25.5%) 05(11.4%) 2.6 0.8 – 8.2 0.11
Prior Hx of IDA therapy ¶¶ 07(13.7%) 02(4.5%) 3.3 0.6 – 0.9 0.14
Biochemical Variables
Hb≤ (gm/dl) Mean (SD) 6.6(1.9) 7.5(2.1) 0.8 0.6 – 0.9 0.04
Hb ≤ 9 gm/dl ‡ 46(90.2%) 29(65.9%) 4.7 1.5 – 14.4 0.004
MCV (fl) Mean (SD) 60.3(5.6) 62.2(5.6) 0.9 0.8 – 1.0 0.1
MCV ≤ 60 fl ‡‡ 32(62.7%) 14(31.8%) 3.6 1.5 – 8.4 0.003
Serum Iron (μg/dl) Mean(SD) 10.5(6.8) 12.5(5.1) 0.9 0.8 – 1.0 0.13
Serum Iron ≤ 10 (μg/dl) * 31(60%) 19(43.0%) 2.0 0.8 – 4.6 0.08
TIBC (μg/dl) Mean (SD) 396(88) 379(79) 1.0 0.9 – 1.0 0.33
Transferrin saturation (%) 
Mean (SD)
4.4(4.4) 4.1(4.1) 1.0 0.9 – 1.2 0.47
Ferritin (ng/ml) Mean (SD) 6.3(4.2) 5.8(3.3) 1.03 0.9 – 1.1 0.54
Ferritin ≤ 5 (ng/ml) ** 28(54.9%) 18(40.9%) 1.75 0.7 – 3.9 0.17
FOB (Positive) *** 27(52.9%) 03(6.8%) 15.3 4.2 – 56.1 <0.001
Reference groups: †Age <55 yrs; ††No NSAIDS use; ††† No Hx of weight loss; ¶No Hx of Fatigue/Lethargy; ¶¶ No Prior Hx of IDA therapy; ‡ Hb 
> 9 gm/dl; ‡‡ MCV>60 fl; * Serum Iron > 10 (μg/dl); ** Ferritin> 5 (ng/ml); *** FOB (Negative)
Table 4: Multivariable Logistic regression analysis; independent predicators of bleeding related endoscopic lesion
Variable P value Regression coefficients (SE) Adjusted odds ratio 95% Confidence Interval
Age (Years) 0.002 0.05 (0.01) 1.05 1.02 – 1.07
Fecal Occult Blood Positive <0.001 2.8 (0.72) 16.4 3.9 – 67.3
MCV ≤ 60 (fl) 0.01 1.2 (0.53) 3.5 1.2 – 10.0Page 5 of 7
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lesions in IDA patients without GI symptoms, however,
hemoglobin, ferritin, female gender and history of
NSAIDs have been shown to be associated with endo-
scopic lesions in patients with IDA having gastrointestinal
symptoms [8,10,28]. In the current study there was no
correlation with the factors described in patients with GI
symptoms. However, our results of advancing age, low
mean corpuscular volume and positive fecal occult blood
test are in concordance with the available literature of IDA
patients.
The main limitation of our study is that we did not inves-
tigate patients with negative endoscopies with capsule
endoscopy and/or enteroscopy.
In conclusion, patients with iron deficiency anemia with-
out gastrointestinal symptoms obligates comprehensive
gastrointestinal tract examination especially with advance
age, low mean corpuscular volume and positive fecal
occult blood test, as large proportion of patients may have
potentially treatable etiology. High proportion of upper
gastrointestinal lesions warrants upper gastrointestinal
endoscopy as initial endoscopic procedure in patients
with iron deficiency anemia with out gastrointestinal
symptoms. However these conclusions need validation in
further studies.
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Table 5: Univariate analysis: Clinical and biochemical factors related to cause of iron deficiency anaemia in patients with out 
gastrointestinal symptoms
Cause of Iron Deficiency 
Identified (n = 68)
Cause of Iron deficiency not 
identified (n = 27)
Odds ratio 95% CI P value
Clinical variables
Age (yrs) Mean (SD) 55(14) 44(20) 1.04 1.01 – 1.07 0.004
Age ≥ 55 yrs † 34(50%) 06(22.2%) 3.5 1.2 – 9.7 0.01
NSAID users †† 18(26.5%) 04(14.8%) 2.0 0.6 – 6.8 0.22
Hx of Weight loss ††† 19(27.9%) 10(37.03%) 0.6 0.2 – 1.6 0.38
Hx of Fatigue/Lethargy ¶ 16(23.5%) 02(7.4%) 3.8 0.8 – 18 0.08
Prior Hx of IDA therapy ¶¶ 08(11.8%) 01(3.7%) 3.4 0.4 – 29.1 0.43
Biochemical Variables
Hb (gm/dl) Mean (SD) 6.9(1.9) 7.3(2.2) 0.9 0.7 – 1.1 0.44
Hb ≤ 9 gm/dl ‡ 57(83.8%) 18(66.7%) 2.5 0.9 – 7.2 0.06
MCV (fl) Mean (SD) 60.0(5.5) 64.0(4.7) 0.8 0.7 – 0.9 0.002
MCV 60 fl ‡‡ 43(63.2%) 03(11.1%) 13.7 3.7 – 50.3 <0.001
Serum Iron (μg/ml) Mean 
(SD)
11.5(6.5) 11.3(5.1) 1.0 0.9 – 1.0 0.86
Serum Iron ≤ 10 (μg/ml)* 35(51.4%) 15(55.5%) 0.85 0.3 – 2.0 0.71
TIBC (μg/dl) Mean (SD) 399(82) 361(85) 1.0 1.0 – 1.01 0.04
Transferrin saturation (%) 
Mean (SD)
4.3(2.7) 4.1(2.0) 1.9 0.7 – 4.9 0.67
Ferritin (ng/ml) Mean (SD) 6.0(4.0) 6.1(3.3) 0.99 0.8 – 1.1 0.88
Ferritin ≤ 5 (ng/ml) ** 36(52.9%) 10(37.0%) 1.9 0.7 – 4.7 0.17
FOB (Positive) *** 28(41.2%) 02(7.4%) 8.7 1.9 – 39.9 0.001
Reference groups: †Age <55 yrs; ††No NSAIDS use; ††† No Hx of weight loss; ¶No Hx of Fatigue/Lethargy; ¶¶ No Prior Hx of IDA therapy; ‡ Hb 
> 9 gm/dl; ‡‡ MCV>60 fl; * Serum Iron > 10 (μg/dl); ** Ferritin> 5 (ng/ml); *** FOB (Negative)
Table 6: Multivariable logistic regression: Predictors for cause of iron deficiency in patients without gastrointestinal symptoms
Variable P value Regression coefficients (SE) Adjusted odds ratio 95% Confidence Interval
Age (Years) 0.01 0.04 (0.01) 1.04 1.01 – 1.08
Fecal Occult Blood Positive 0.01 2.0 (0.85) 7.8 1.46 – 41.8
MCV ≤ 60(fl) < 0.001 2.7 (0.71) 14.8 3.65 – 60.7Page 6 of 7
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Graph showing ROC curve for cause of iron deficiency anae-miaFigure 3
Graph showing ROC curve for cause of iron defi-
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